news

HeMo China at CSA and TISC 2021

HeMo China was present at CSA & TISC 2021, this year’s edition of the Annual Scientific Session of Chinese Stroke Association (CSA) and Tiantan International Stroke Conference (TISC).  At the symposium, HeMo China also marked the commercial launch of its Afentta™ and FocuStar™ products with a series of academic promotion activities.

HeMo Receives NMPA Approval for Afentta™ Aspiration Catheter

HeMo Bioengineering Ltd (“HeMo”), a Singapore-based medical device company with a focus on treating stroke patients, is pleased to announce that its Afentta™ intracranial thrombectomy aspiration catheter – a product developed by HeMo’s branch in China – has received pre-market approval from the National Medical Products Administration (“NMPA”), becoming the first approved domestic product of …

HeMo Receives NMPA Approval for Afentta™ Aspiration Catheter Read More »